Clinical Trial Detail

NCT ID NCT01723800
Title PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center|National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

Therapies

Buparlisib + Carboplatin + Pemetrexed Disodium

Age Groups: adult

No variant requirements are available.